Kadcyla-160mg (Trastuzumab emtansine Vials) 160mg

Kadcyla 160mg (trastuzumab emtansine) is an antibody-drug conjugate used in cancer therapy. This single-dose vial supports targeted treatment with precise dosing. Store between 2-8°C to maintain potency. Ideal for oncology protocols requiring trastuzumab-based regimens.

Strength

160mg

Pack Size

Storage

2-8°

Manufacturer / TM Owner

Genentech, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Trastuzumab emtansine is used to treat certain types of HER2-positive breast cancer. It combines trastuzumab with a chemotherapy agent for targeted delivery. Patients with metastatic or early-stage breast cancer may receive this medication. The 160mg strength supports standard dosing cycles in clinical settings.

Side Effects

This medication works by binding to HER2 receptors on cancer cells, delivering chemotherapy directly to the tumor. Patients may experience fatigue or gastrointestinal effects during treatment. Hair loss and low blood cell counts are commonly reported. Individual responses vary based on treatment stage and health status.

Precautions & Warnings

Store vials refrigerated between 2-8°C and protect from light. Avoid freezing or shaking the vial. Use within the specified timeframe after preparation. Healthcare professionals should handle this medication with standard precautions for cytotoxic drugs.

Avoid Interactions

Concurrent use with strong CYP3A4 inhibitors may increase trastuzumab emtansine levels. Avoid live vaccines during treatment due to potential immune response interference. Some medications may affect how this drug is processed in the body. Discuss all current medications with your healthcare provider before starting treatment.

Frequently Asked Questions

Kadcyla 160mg is used to treat HER2-positive breast cancer in adults.

Store between 2-8°C and protect from light. Do not freeze or shake the vial.

Common effects include fatigue, nausea, and low blood cell counts.

Avoid live vaccines during treatment unless approved by your doctor.

Availability varies by region and prescription requirements.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.